We performed a second round of optimization using the anti-MALAT1 gapmer and iPSC-derived neuronal progenitor cells (iPSC-NPCs) F4259 that originated from an FRDA patient and contained 340 and 690 expanded GAA repeat within the FXN gene (Fig. 2C,D). The gene discussed is FXN; the disease is Friedreich ataxia.